Pathophysiology and treatment of diabetic retinopathy

被引:143
作者
Bandello, Francesco [1 ]
Lattanzio, Rosangela [1 ]
Zucchiatti, Ilaria [1 ]
Del Turco, Claudia [1 ]
机构
[1] Univ Vita Salute, San Raffaele Sci Inst, Dept Ophthalmol, Milan, Italy
关键词
Diabetic macular edema; Proliferative diabetic retinopathy; Laser; Intravitreal anti-VEGF; Dexamethasone implant; Vitrectomy; ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL TRIAMCINOLONE ACETONIDE; DRUG-DELIVERY SYSTEM; RANDOMIZED CONTROLLED-TRIAL; MICROPULSE DIODE-LASER; PARS-PLANA VITRECTOMY; VEGF TRAP-EYE; MACULAR EDEMA; PANRETINAL PHOTOCOAGULATION; FLUOCINOLONE ACETONIDE;
D O I
10.1007/s00592-012-0449-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the past years, the management of diabetic retinopathy (DR) relied primarily on a good systemic control of diabetes mellitus, and as soon as the severity of the vascular lesions required further treatment, laser photocoagulation or vitreoretinal surgery was done to the patient. Currently, even if the intensive metabolic control is still mandatory, a variety of different clinical strategies could be offered to the patient. The recent advances in understanding the complex pathophysiology of DR allowed the physician to identify many cell types involved in the pathogenesis of DR and thus to develop new treatment approaches. Vasoactive and proinflammatory molecules, such as vascular endothelial growth factor (VEGF), play a key role in this multifactorial disease. Current properly designed trials, evaluating agents targeting VEGF or other mediators, showed benefits in the management of DR, especially when metabolic control is lacking. Other agents, directing to the processes of vasopermeability and angiogenesis, are under investigations, giving more hope in the future management of this still sight-threatening disease.
引用
收藏
页码:1 / 20
页数:20
相关论文
共 207 条
  • [1] Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy
    Abraham, Prema
    Adelman, Ron A.
    Alfaro, Daniel Virgil, III
    Anand, Rajiv
    Antoszyk, Andrew
    Bergsma, Donald
    Hartnett, Mary Elizabeth
    Brucker, Alexander J.
    Carr, Tyree
    Casey, Raynor C.
    Rubino, John
    Chandler, Thomas W.
    Charles, Steven
    Chaudhry, Nauman
    Combs, James
    Doft, Bernard
    Young, Lucy H. Y.
    Drouilhet, John H.
    Dugel, Pravin U.
    Feman, Stephen S.
    Finkelstein, Daniel
    Foster, Robert E.
    Petersen, Michael R.
    Fox, Gregory
    Garretson, Bruce
    Gieser, Jon P.
    Gentile, Ronald C.
    Giovinazzo, Vincent
    Glazer, Louis
    Goodart, Roy A.
    Gottlieb, Justin
    Greven, Craig
    Grizzard, William S.
    Hainsworth, Dean P.
    Halperin, Lawrence
    Heier, Jeffrey S.
    Jackson, William
    Kubacki, Joseph J.
    Kanter, Eric D.
    Keyser, Bruce
    Kingsley, Ronald
    Ko, Paula
    Kokame, Gregg T.
    Kuppermann, Baruch
    Lambert, H. Michael
    Lewis, Hilel
    Lewis, Richard Alan
    Marcus, Dennis
    Nussbaum, Julian
    Maturi, Raj K.
    [J]. OPHTHALMOLOGY, 2006, 113 (12) : 2221 - 2230
  • [2] Immunological mechanisms in the pathogenesis of diahetic retinopathy
    Adamis, Anthony P.
    Berman, Adrienne J.
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2008, 30 (02) : 65 - 84
  • [3] Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
    Adamis, AP
    Altaweel, M
    Bressler, NM
    Cunningham, ET
    Davis, MD
    Goldbaum, M
    Gonzales, C
    Guyer, DR
    Katz, B
    Patel, M
    [J]. OPHTHALMOLOGY, 2006, 113 (01) : 23 - 28
  • [4] Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor
    Aiello, LP
    Bursell, SE
    Clermont, A
    Duh, E
    Ishii, H
    Takagi, C
    Mori, F
    Ciulla, TA
    Ways, K
    Jirousek, M
    Smith, LEH
    King, GL
    [J]. DIABETES, 1997, 46 (09) : 1473 - 1480
  • [5] HYPOXIC REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN RETINAL CELLS
    AIELLO, LP
    NORTHRUP, JM
    KEYT, BA
    TAKAGI, H
    IWAMOTO, MA
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (12) : 1538 - 1544
  • [6] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [7] [Anonymous], 1990, Arch Ophthalmol, V108, P958
  • [8] [Anonymous], 1978, Ophthalmology, V85, P82
  • [9] [Anonymous], 1976, AM J OPHTHALMOL, V81, P383
  • [10] [Anonymous], 1987, Int Ophthalmol Clin, V27, P265